288 288 correctly predicted forecasts
Send me real-time posts from this site at my email
Voting is over

Nektar Therapeutics Will Not Fall Below $50
13 june

The market's misinterpretation of Nektar Therapeutics' $NKTR clinical results created an opportunity for those who missed the run. Now in correction mode, this stock will not fall below $50. 

$NKTR, NEKTAR THERAPEUTICS / H1

Agree or disagree?

Login to vote. Free to sign-up.

Answered:
12 people

Nektar Therapeutics Will Not Fall Below $50

Voting is over
Waiting for
the right answer
Agreed
9 people
Disagreed
3 people